Morgan Stanley Maintains Equal-Weight on TransMedics Group, Raises Price Target to $37

Morgan Stanley analyst Cecilia Furlong maintains TransMedics Group (NASDAQ:TMDX) with a Equal-Weight and raises the price target from $34 to $37.

Morgan Stanley analyst Cecilia Furlong maintains TransMedics Group (NASDAQ:TMDX) with a Equal-Weight and raises the price target from $34 to $37.

Total
0
Shares
Related Posts